(0.48%) 5 042.49 points
(0.50%) 38 094 points
(0.94%) 15 752 points
(-0.56%) $78.56
(5.28%) $2.03
(-0.11%) $2 308.40
(0.05%) $26.76
(0.67%) $961.30
(0.12%) $0.934
(0.06%) $11.04
(0.15%) $0.800
(-1.62%) $91.75
Quarter results tomorrow
(bmo 2024-05-03)
Expected move: +/- 10.42%
Live Chart Being Loaded With Signals
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland...
Stats | |
---|---|
Šios dienos apimtis | 330 887 |
Vidutinė apimtis | 336 670 |
Rinkos kapitalizacija | 1.31B |
EPS | $0 ( 2024-02-26 ) |
Kita pelno data | ( $0 ) 2024-05-03 |
Last Dividend | $0.100 ( 2012-09-26 ) |
Next Dividend | $0 ( N/A ) |
P/E | -62.49 |
ATR14 | $0.901 (0.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-13 | Davis Stephen L | Sell | 500 | Common Stock |
2023-06-13 | Hasenmaier Joachim A. | Sell | 2 004 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 4 056 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 33 111 | Common Stock |
2022-02-28 | Eyl Steven M. | Buy | 20 000 | Non-Qualified Stock Option (right to buy) |
INSIDER POWER |
---|
-9.06 |
Last 100 transactions |
Buy: 575 941 | Sell: 596 011 |
Tūris Koreliacija
Heska Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ATCX | 0.919 |
BRACU | 0.916 |
SYKE | 0.912 |
SPRB | 0.905 |
XLRN | 0.905 |
GRNQ | 0.902 |
JFIN | 0.893 |
ICON | 0.89 |
RDUS | 0.888 |
AEYE | 0.883 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AHPI | -0.894 |
SBBP | -0.887 |
TUEM | -0.88 |
VIEW | -0.872 |
VERA | -0.867 |
GRPH | -0.858 |
ARDS | -0.856 |
RPTX | -0.845 |
NAKD | -0.83 |
YJ | -0.829 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Heska Corp Koreliacija - Valiuta/Žaliavos
Heska Corp Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $257.31M |
Bruto pelnas: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2022 |
Pajamos: | $257.31M |
Bruto pelnas: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2021 |
Pajamos: | $253.74M |
Bruto pelnas: | $105.79M (41.69 %) |
EPS: | $-0.110 |
FY | 2020 |
Pajamos: | $197.32M |
Bruto pelnas: | $81.29M (41.20 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
Heska Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2012-03-28 |
Last Dividend | $0.100 | 2012-09-26 |
Next Dividend | $0 | N/A |
Payout Date | 2012-10-10 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.56 | -- |
Div. Sustainability Score | 3.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.0941 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.300 | 4.08% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.106 | 1.500 | -2.12 | -3.18 | [0 - 0.5] |
returnOnAssetsTTM | -0.0230 | 1.200 | -0.766 | -0.920 | [0 - 0.3] |
returnOnEquityTTM | -0.0324 | 1.500 | -1.472 | -2.21 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.64 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.82 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.96 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.185 | -1.500 | 6.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.49 | 1.000 | -4.25 | -4.25 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.708 | -1.417 | [0 - 20] |
debtEquityRatioTTM | 0.262 | -1.500 | 8.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.429 | 1.000 | 6.18 | 6.18 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0920 | 1.000 | -3.84 | -3.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.113 | 1.000 | -1.737 | -1.737 | [0.2 - 2] |
assetTurnoverTTM | 0.217 | 0.800 | -1.886 | -1.508 | [0.5 - 2] |
Total Score | 3.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -91.49 | 1.000 | -9.34 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0324 | 2.50 | -0.946 | -2.21 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.472 | -1.417 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.830 | 1.500 | -8.87 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0957 | 1.000 | -4.89 | 0 | [0.1 - 0.5] |
Total Score | -2.83 |
Heska Corp
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.